NO20075898L - Treatment of community acquired pneumonia by administration of tissue factor pathway inhibitor (TFPI) - Google Patents

Treatment of community acquired pneumonia by administration of tissue factor pathway inhibitor (TFPI)

Info

Publication number
NO20075898L
NO20075898L NO20075898A NO20075898A NO20075898L NO 20075898 L NO20075898 L NO 20075898L NO 20075898 A NO20075898 A NO 20075898A NO 20075898 A NO20075898 A NO 20075898A NO 20075898 L NO20075898 L NO 20075898L
Authority
NO
Norway
Prior art keywords
tfpi
tissue factor
pathway inhibitor
factor pathway
administration
Prior art date
Application number
NO20075898A
Other languages
Norwegian (no)
Inventor
Abla Creasey
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2006/013890 external-priority patent/WO2006113360A2/en
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of NO20075898L publication Critical patent/NO20075898L/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Fremgangsmåter for profylaktisk eller terapeutisk å behandle alvorlig lungebetennelse som involverer å gi vevsfaktor pathway inhibitor (TFPI) eller en TFPI analog til pasienter som lider av eller som er i risikosonen for å utvikle denne tilstand. Fremgangsmåten involverer anvendelsen av kontinuerlig intravenøs infusjon av TFPI eller en TFPI analog helst ved lave doser for å unngå alvorlige bieffekter.Methods for prophylactic or therapeutic treatment of severe pneumonia involving providing tissue factor pathway inhibitor (TFPI) or a TFPI analogue to patients suffering from or at risk of developing this condition. The method involves the use of continuous intravenous infusion of TFPI or a TFPI analogue preferably at low doses to avoid serious side effects.

NO20075898A 2005-04-15 2007-11-15 Treatment of community acquired pneumonia by administration of tissue factor pathway inhibitor (TFPI) NO20075898L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67144605P 2005-04-15 2005-04-15
PCT/US2006/013890 WO2006113360A2 (en) 2005-04-15 2006-04-14 Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor(tfpi)

Publications (1)

Publication Number Publication Date
NO20075898L true NO20075898L (en) 2008-01-11

Family

ID=39204622

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075898A NO20075898L (en) 2005-04-15 2007-11-15 Treatment of community acquired pneumonia by administration of tissue factor pathway inhibitor (TFPI)

Country Status (1)

Country Link
NO (1) NO20075898L (en)

Similar Documents

Publication Publication Date Title
NO20076245L (en) Use of TFPI to treat severe bacterial infections
Nunes et al. Disuse-induced skeletal muscle atrophy in disease and nondisease states in humans: mechanisms, prevention, and recovery strategies
Chang et al. Medial prefrontal cortex activation facilitates re-extinction of fear in rats
NO20051987L (en) Treatment of fungal infections.
MXPA04003548A (en) Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi).
NO20091296L (en) Procedure for the treatment of thrombolytic agents
WO2006037031A3 (en) Formulations and methods for treatment of inflammatory diseases
WO2009039397A3 (en) Substituted amides, methods of making, use thereof for the treatment of diseases such as cancer
EA201170669A1 (en) TREATMENT OF PYRPHENIDONE PATIENTS WITH ATYPICAL LIVER FUNCTION
NZ572049A (en) Method for treatment of constipation-predominant irritable bowel syndrome
NO20064964L (en) Treatment of impaired respiratory function
NO20051669L (en) Methods and Reagents for the Treatment of Diseases and Disorders Associated with Increased Levels of Proinflammatory Cytokines
EA202193019A1 (en) TREATMENT OF HEREDITARY ANGIOEDEMA
WO2009099642A3 (en) Proteomic analysis of active multiple sclerosis lesions
WO2005117937A3 (en) Alpha-1- acid glycoprotein for the treatment of diabetes
NO20064674L (en) Treatment of Severe Pneumonia Acquired Out of Hospital by Tissue Factor Pathway Inhibitor Administration
NO20075898L (en) Treatment of community acquired pneumonia by administration of tissue factor pathway inhibitor (TFPI)
Chang et al. Propofol-enhanced autophagy increases motility and angiogenic capacity of cultured human umbilical vascular endothelial cells
NZ708511A (en) Methods for controlling blood pressure and reducing dyspnea in heart failure
NO20060655L (en) 2-alkylidene-19-nor-vitamin D derivatives for the treatment of male osteophenia or osteoporosis
TNSN07386A1 (en) Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (tfpi)
BR0112100A (en) Method of treatment of peripheral vascular diseases, peripheral neuropathies and autonomic neuropathies
NO20073942L (en) Pharmaceutical compositions for the treatment of diseases associated with NF-κB activity
Arya et al. PS 04-10 KAEMPFEROL ATTENUATES MYOCARDIAL ISCHEMIC INJURY VIA INHIBITION OF MAPK SIGNALING PATHWAY IN EXPERIMENTAL MODEL OF MYOCARDIAL ISCHEMIA-REPERFUSION INJURY
Landin et al. MK-7 enhances expression of genes related to bone, enamel and dentin, and reduces the expression of genes related to apoptosis in developing murine molars

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application